A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck

PHASE2RecruitingINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

December 25, 2024

Study Completion Date

January 23, 2025

Conditions
Squamous Cell Carcinomas of the Head and Neck
Interventions
DIETARY_SUPPLEMENT

Fucoidan

Fucoidan refers to a class of fucose-enriched sulfated polysaccharides with an average molecular weight of 20,000 Daltons (Da), which can be found in many varieties of edible brown seaweeds and algae . In cell culture studies and animal studies, fucoidan has been shown to possess a range of biological activities, including anti-cancer, anti-inflammatory, and immunoregulatory effects . A recent in vitro study conducted in head and neck squamous cell carcinoma (HNSCC) cell lines (H103, FaDu, and KB) showed that fucoidan could induce cell cycle arrest and possibly apoptosis in a dose-dependent manner, while also enhancing response to cisplatin treatment . In addition, fucoidan has also been shown to inhibit the proliferation of nasopharyngeal carcinoma cells and MC3 human mucoepidermoid carcinoma (MEC) cells .

OTHER

Placebo( Potato starch)

Potato starch 4.4gram

Trial Locations (1)

100225

RECRUITING

National Taiwan University Hospital, Taipei County

All Listed Sponsors
lead

Hi-Q Marine Biotech International, Ltd.

INDUSTRY